Renal and Red Marrow Dosimetry in Peptide Receptor Radionuclide Therapy: 20 Years of History and Ahead
Round 1
Reviewer 1 Report
The review entitled“Renal i red marrow dosimetry in peptide receptor radionuclide therapy: 20 years of history and ahead” by the authors Walrand and Jamar represents a very good and interesting summary in the field of dosimetry of commonly used radiopharmaceuticals 177Lu-DOTATATE and 90Y-DOTATOC in PRRT of cancers expressing somatostatin receptors.
The manuscript is well written, clear and easy to read. Title and abstract are accurate. The topics covered in this review are well and precisely discussed, and references are well cited. I suggest accepting manuscript at present form after minor coorections.
Please consider the following comments:
- Please insert more visible pictures (in better resolution) of Figure 1 and Figure 2
- Line 115 - caption of the Figure 2 is not describe precisely. Reprinted from [22] with permission of……?????
Author Response
We corrected caption of figure 2 and reference 22
Unfortunately figures 1 and 2 are reprinted from papers, and we cannot change the resolution
Reviewer 2 Report
please find in the attachment your revised paper with some minor comments/suggestions
Comments for author File: 
Comments.pdf
Author Response
we made the requested corrections
